These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27965999)

  • 41. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium.
    Fagard RH; Van Den Enden M; Leeman M; Warling X
    J Hypertens; 2002 Jul; 20(7):1297-302. PubMed ID: 12131525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unhealthy behaviors and risk of uncontrolled hypertension among treated individuals-The CONSTANCES population-based study.
    Cherfan M; Vallée A; Kab S; Salameh P; Goldberg M; Zins M; Blacher J
    Sci Rep; 2020 Feb; 10(1):1925. PubMed ID: 32024888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.
    Petrella RJ; Tremblay G; De Backer G; Gill DP;
    Vasc Health Risk Manag; 2014; 10():63-74. PubMed ID: 24493928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved blood pressure control in elderly hypertensive patients: results of the PAPY-65 Survey.
    Van der Niepen P; Dupont AG
    Drugs Aging; 2010 Jul; 27(7):573-88. PubMed ID: 20583851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM; Glynn RJ; Danielson E; Ridker PM;
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood Pressure Control among Hypertensive Stroke Survivors in Nigeria.
    Wahab KW; Kolo PM; Salawu FK; Sanya EO
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1222-1227. PubMed ID: 28189571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional Study.
    Chowdhury EK; Nelson MR; Ernst ME; Margolis KL; Beilin LJ; Johnston CI; Woods RL; Murray AM; Wolfe R; Storey E; Shah RC; Lockery JE; Tonkin AM; Newman AB; Williamson JD; Abhayaratna WP; Stocks NP; Fitzgerald SM; Orchard SG; Trevaks RE; Donnan GA; Grimm R; McNeil JJ; Reid CM;
    Am J Hypertens; 2020 Apr; 33(4):350-361. PubMed ID: 31807750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure?
    Floor-Schreudering A; De Smet PA; Buurma H; Kramers C; Tromp PC; Belitser SV; Bouvy ML
    Eur J Prev Cardiol; 2015 Jan; 22(1):91-9. PubMed ID: 24042856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of metabolic risk factors with uncontrolled hypertension: comparison of the several definitions of metabolic syndrome.
    Cortez-Dias N; Martins SR; Belo A; Fiuza M;
    J Hypertens; 2013 Oct; 31(10):1991-7. PubMed ID: 23811998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Achieving blood preSsure goals sTudy in uncontrolled hypeRtensive pAtients treated with a fixed-dose combination of ramipriL/hydrochlorothiazide: the ASTRAL study.
    Okpechi IG; Schoeman HS; Longo-Mbenza B; Oke DA; Kingue S; Nkoua JL; Rayner BL
    Cardiovasc J Afr; 2011; 22(2):79-84. PubMed ID: 21556450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension.
    Lepira FB; Kayembe PK; M'buyamba-Kabangu JR; Nseka MN
    Cardiovasc J S Afr; 2006; 17(1):7-11. PubMed ID: 16547554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Awareness, Prevalence, Treatment, and Control of Hypertension in Western Nepal.
    Neupane D; Shrestha A; Mishra SR; Bloch J; Christensen B; McLachlan CS; Karki A; Kallestrup P
    Am J Hypertens; 2017 Sep; 30(9):907-913. PubMed ID: 28531244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of blood pressure control in adult hypertensive patients in eastern Sudan.
    Omar SM; Elnour O; Adam GK; Osman OE; Adam I
    BMC Cardiovasc Disord; 2018 Feb; 18(1):26. PubMed ID: 29415657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and control of high blood pressure in primary care: results from the German Metabolic and Cardiovascular Risk Study (GEMCAS).
    Balijepalli C; Bramlage P; Lösch C; Zemmrich C; Humphries KH; Moebus S
    Hypertens Res; 2014 Jun; 37(6):580-4. PubMed ID: 24621471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohort.
    Barengo NC; Antikainen R; Kastarinen M; Laatikainen T; Tuomilehto J
    J Hum Hypertens; 2013 Nov; 27(11):693-7. PubMed ID: 23514844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.